MedPath

Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes

Not Applicable
Recruiting
Conditions
Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
Female
Adult
Endothelial Function (reactive Hyperemia)
Arterial Stiffness
Cognition
Oxidative Stress
Gut Microbiota
Overweight
Inflammation
Registration Number
NCT06735651
Lead Sponsor
Georgia State University
Brief Summary

The goal of this clinical trial is to determine the effectiveness of using a freeze-dried wild blueberry powder on cardiometabolic health, cognitive function, and gut microbiota composition in adult women with prediabetes.

Detailed Description

In the U.S., 35.3 million adults have type 2 diabetes mellitus (T2DM) and 96 million have prediabetes. Eight out of 10 people with T2DM die from cardiovascular disease. People with T2DM also have a 50% higher risk of developing dementia compared to healthy counterparts. Further, studies show that gut microbes play a major role in the development of T2DM. Prevention and treatment of T2DM focus on lifestyle changes including dietary modifications such as increased consumption of deep-colored fruits like berries. Blueberries are rich in fiber and phytochemicals and have several health benefits. We and others have shown that blueberry intake improves heart health in healthy men, hypertensive postmenopausal women, and men and women with metabolic syndrome. Yet, a comprehensive study in women with prediabetes that measures changes in cognitive performance and the underlying heart and gut health has not been conducted to date. Thus, the overall objective of this study is to investigate and bring forth evidence that blueberries improve gut, cardiometabolic, and cognitive function in women with prediabetes.

Therefore, this pilot six-week randomized, placebo-controlled parallel-arm clinical trial aims to investigate whether daily consumption of 22 g of freeze-dried blueberry powder improves gut, cardiometabolic, and cognitive function in women with prediabetes. Investigators hypothesize that daily consumption of blueberries will improve cardiometabolic parameters, gut dysbiosis, and cognitive impairments in our study population. To test these hypotheses, the following specific aims are proposed. To investigate whether daily consumption of 22 g of freeze-dried blueberry powder:

* Reduces levels of fasting blood glucose (FBG), insulin, and HOMA-IR (homeostatic model assessment of insulin resistance) and improves lipid profile in women with prediabetes.

* Reduces blood pressure and improves endothelial function in women with prediabetes.

* Improves cognitive function (verbal memory and executive functions \[inhibition, working memory, cognitive flexibility\]) in women with prediabetes.

* Favorably modulates gut microbiota composition in women with prediabetes.

* Improves serum markers of oxidative stress and inflammation in women with prediabetes.

Additionally, whether changes in the gut microbiota are associated with changes in cardiometabolic and cognitive function outcomes and whether changes in cardiometabolic outcomes are associated with changes in cognitive function parameters will be explored.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Women aged 45-65 years old
  • Prediabetes (fasting blood glucose 100-125 mg/dL and/or HbA1c percentage between 5.7-6.4)
  • Body Mass Index between 25-30 kg/m^2
Exclusion Criteria
  • Allergies to berries
  • Use of insulin, antidiabetic, antibiotics, and anti-inflammatory drugs
  • Active cancer, gastrointestinal, renal, thyroid, stage 1 & 2 hypertension and other cardiovascular diseases, neurological diseases, or severe head injury
  • Smoking
  • Consumes greater than 2 alcoholic beverages per day
  • Consumes antioxidant, probiotic, and prebiotic supplements
  • Pregnant or Lactating
  • Actively participating in a weight loss program
  • Currently taking berry supplements or recently participated in another study taking berry supplements

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Blood GlucoseBaseline and 6 weeks

Measurement of fasting blood glucose

Ambulatory Blood PressureBaseline and 6 weeks

Assessment of whole-day ambulatory blood pressure during daytime and nighttime periods.

Secondary Outcome Measures
NameTimeMethod
Fasting InsulinBaseline and 6 weeks
Homeostasis model assessment-insulin resistance (HOMA-R)Baseline and 6 weeks

Calculated as fasting insulin (mU/mL) x fasting glucose (mg/dL)/405

Blood Lipid ProfileBaseline and 6 weeks

Measurement of blood lipid profile

Associative MemoryBaseline and 6 months

Measured using NIH Toolbox Face Name Associative Memory Exam and Face Name Associative Memory Exam Delay tests

Gut Microbiota CompositionBaseline and 6 weeks

Analysis of stool sample for determination of absolute levels of bacteria and relative species composition

Global Cognitive AbilityScreening

Measured using NIH Toolbox Picture Vocabulary test and Oral Reading Recognition

Performance ValidityBaseline and 6 weeks

Assessed using Rey 15

Verbal Memory & RecognitionBaseline and 6 weeks

Measured using Rey Auditory Verbal Learning Test with appropriate alternate forms

Working MemoryBaseline and 6 weeks

Measured using Digit Span and NIH Toolbox List Sorting

Processing SpeedBaseline and 6 weeks

Measured using NIH Toolbox Pattern Comparison and Oral Symbol Digit tests

Cognitive InhibitionBaseline and 6 weeks

Measured using Delis-Kaplan Executive Function System Color Word Interference, and NIH Toolbox Flanker Inhibitory Control and Attention

Cognitive FlexibilityBaseline and 6 weeks

Assessed using Delis-Kaplan Executive Function System Trails and Verbal Fluency Switching

AttentionBaseline and 6 weeks

Assessed using Wechsler Adult Intelligence Scale - IV and Rey Auditory Verbal Learning Test Trial 1.

Problem-SolvingBaseline and 6 weeks

Assessed using NIH Toolbox Visual Reasoning Test

Trial Locations

Locations (1)

Georgia State University

🇺🇸

Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath